Cost-Effectiveness of Targeting Patients Undergoing Percutaneous Coronary Intervention for Therapy With Bivalirudin Versus Heparin Monotherapy According to Predicted Risk of Bleeding-Reference-Cited by-同舟云学术

Cost-Effectiveness of Targeting Patients Undergoing Percutaneous Coronary Intervention for Therapy With Bivalirudin Versus Heparin Monotherapy According to Predicted Risk of Bleeding

Published:2010-07 Issue:4 Volume:3 Page:358-365
ISSN:1941-7713
Container-title:Circulation: Cardiovascular Quality and Outcomes
language:en
Short-container-title:Circ Cardiovasc Qual Outcomes

Author:

Amin Amit P.¹,Marso Steven P.¹,Rao Sunil V.¹,Messenger John¹,Chan Paul S.¹,House John¹,Kennedy Kevin¹,Robertus Katherine¹,Cohen David J.¹,Mahoney Elizabeth M.¹

Affiliation:

1. From Saint-Luke's Mid America Heart Institute (A.P.A., S.P.M., P.S.C., J.H., K.K., K.R., D.J.K., E.M.M.), Kansas City, Mo; Duke University Medical Center (S.V.R.), Durham, NC; and the University of Colorado (J.M.), Aurora, Colo.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Bleeding, Blood Transfusion, and Increased Mortality After Percutaneous Coronary Intervention

2. Trends in the Prevalence and Outcomes of Radial and Femoral Approaches to Percutaneous Coronary Intervention

3. Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: A proposal from the Academic Bleeding Consensus (ABC) Multidisciplinary Working Group

4. Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention

5. Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary InterventionREPLACE-2 Randomized Trial

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of net adverse clinical events between bivalirudin and heparin as anticoagulants for percutaneous coronary intervention in Chinese patients;Experimental and Therapeutic Medicine;2023-09-27

2. Percutaneous Coronary Intervention With an Initial Bolus of Low-Dose Heparin in Biomarker-Negative Patients;Cardiovascular Revascularization Medicine;2021-02

3. Radial access and risk guided use of bivalirudin?;Catheterization and Cardiovascular Interventions;2020-11

4. Systematic Incorporation of Sex‐Specific Information Into Clinical Practice Guidelines for the Management of ST‐Segment–Elevation Myocardial Infarction: Feasibility and Outcomes;Journal of the American Heart Association;2019-04-02

5. 2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Guidelines on the Acute Management of ST-Elevation Myocardial Infarction: Focused Update on Regionalization and Reperfusion;Canadian Journal of Cardiology;2019-02